7: GF Signalling II Flashcards
1
Q
How many patients with HER2+ metastasic BC will initially respond to trastuzumab?
A
<50%
2
Q
What are the 3 mechanisms of resistance to trastuzumab
A
- Enzymatic cleavage of HER2 (p95HER2 lacks trastuzumab binding site)
- Epitope masking (interferes with trastuzumab binding & activity)
- Constitutive activation of downstream (PI3K) signalling pathways